| Item 1. | |
| (a) | Name of issuer:
ADARx Pharmaceuticals, Inc. |
| (b) | Address of issuer's principal executive offices:
5871 Oberlin Drive, Suite 200, San Diego, CA 92121 |
| Item 2. | |
| (a) | Name of person filing:
Zhen Li
Zhiqing Zhou
Zhen Li and Zhiqing Zhou, as Co-Trustees of the Titanium Boulder Irrevocable Trust dated July 11, 2020 |
| (b) | Address or principal business office or, if none, residence:
The principal business address of each person named in Item 2(a) is c/o ADARx Pharmaceuticals, Inc., 5871 Oberlin Drive, Suite 200, San Diego, CA 92121. |
| (c) | Citizenship:
Zhen Li is a citizen of the United States.
Zhiqing Zhou is a citizen of the United States.
The Titanium Trust is subject to and governed by the laws of the State of California |
| (d) | Title of class of securities:
Common Stock, $0.0001 par value per share |
| (e) | CUSIP No.:
|
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
| (a) | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
|
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
|
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
|
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
|
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
|
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
|
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
|
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
|
| | |
| Item 4. | Ownership |
| (a) | Amount beneficially owned:
As of September 30, 2026, Zhen Li may be deemed the beneficial owner of 10,800,994 shares of Common Stock, $0.0001 par value per share (the "Common Stock"). This amount consists of (i) 4,939,795 shares of Common Stock subject to options held by Dr. Li that are exercisable within 60 days of September 30, 2026 and (ii) 5,861,199 shares of Common Stock held by the Titanium Trust, for which Dr. Li and Mr. Zhou serve as trustees. Dr. Li and Mr. Zhou, as trustees of the Titanium Trust, share voting and dispositive power with respect to the securities held by the Titanium Trust.
As of September 30, 2026, Zhiqing Zhou may be deemed the beneficial owner of 5,911,763 shares of Common Stock. This amount consists of (i) 50,564 shares of Common Stock subject to options held by Mr. Zhou that are exercisable within 60 days of September 30, 2026 and (ii) 5,861,199 shares of Common Stock held by the Titanium Trust, for which Mr. Zhou and Dr. Li serve as trustees. Mr. Zhou and Dr. Li, as trustees of the Titanium Trust, share voting and dispositive power with respect to the securities held by the Titanium Trust.
As of September 30, 2026, the Titanium Trust may be deemed the beneficial owner of 5,861,199 shares of Common Stock. This amount consists of 5,861,199 shares of Common Stock held by the Titanium Trust, for which Dr. Li and Mr. Zhou serve as trustees. Dr. Li and Mr. Zhou, as trustees of the Titanium Trust, share voting and dispositive power with respect to the securities held by the Titanium Trust. |
| (b) | Percent of class:
As of September 30, 2026, Zhen Li may be deemed to beneficially own approximately 9.6% of the shares of Common Stock outstanding. The foregoing percentage is based on the sum of (i) 107,255,963 shares of Common Stock issued and outstanding as of September 30, 2026 and (ii) 4,939,795 shares of Common Stock issuable upon exercise of options held by Dr. Li within 60 days of September 30, 2026, which shares have been added to the total shares of Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i) under the Exchange Act.
As of September 30, 2026, Zhiqing Zhou may be deemed to beneficially own approximately 5.5% of the shares of Common Stock outstanding. The foregoing percentage is based on the sum of (i) 107,255,963 shares of Common Stock issued and outstanding as of September 30, 2026 and (ii) 50,564 shares of Common Stock issuable upon exercise of options held by Mr. Zhou within 60 days of September 30, 2026, which shares have been added to the total shares of Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i) under the Exchange Act.
As of September 30, 2026, the Titanium Trust may be deemed to beneficially own approximately 5.5% of the shares of Common Stock outstanding. The foregoing percentage is based on 107,255,963 shares of Common Stock issued and outstanding as of September 30, 2026. %
|
| (c) | Number of shares as to which the person has:
|
| | (i) Sole power to vote or to direct the vote:
Zhen Li - 4,939,795.00
Zhiqing Zhou - 50,564.00
Titanium Trust - 0.00
|
| | (ii) Shared power to vote or to direct the vote:
Zhen Li - 5,861,199.00
Zhiqing Zhou - 5,861,199.00
Titanium Trust - 5,861,199.00
|
| | (iii) Sole power to dispose or to direct the disposition of:
Zhen Li - 4,939,795.00
Zhiqing Zhou - 50,564.00
Titanium Trust - 0.00
|
| | (iv) Shared power to dispose or to direct the disposition of:
Zhen Li - 5,861,199.00
Zhiqing Zhou - 5,861,199.00
Titanium Trust - 5,861,199.00
|
| Item 5. | Ownership of 5 Percent or Less of a Class. |
| | |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. |
| |
Not Applicable
|
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
| |
Not Applicable
|
| Item 8. | Identification and Classification of Members of the Group. |
| |
Not Applicable
|
| Item 9. | Notice of Dissolution of Group. |
| |
Not Applicable
|